Is Bcr-Abl expression relevant for the survival of cancer stem cells in chronic myeloid leukaemia (CML)?

被引：0
|
作者：
Helgason, G. V. [1 ]
Hamilton, A. [1 ]
Myssina, S. [2 ]
Jorgensen, H. G. [1 ]
Bhatia, R. [3 ]
Modi, H. [3 ]
Schemionek, M. [4 ]
Koschmieder, S. [4 ]
Brunton, V.
Holyoake, T. L. [1 ,5 ]
机构：
[1] Univ Glasgow, Fac Med, Paul Ogorman Leukaemia Res Ctr, Sect Expt Haematol,Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland
[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] City Hope Hosp, Dept Haematol, Duarte, CA USA
[4] Univ Munster, Dept Haematol & Med Oncol, D-4400 Munster, Germany
[5] Univ Edinburgh, Inst Genet & Mol Med, Div Canc Biol, Edinburgh, Midlothian, Scotland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2010年 / 149卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] Dendritic cells become BCR-ABL negative in chronic myeloid leukaemia patients successfully treated with imatinib
    Wang, L
    Butt, NM
    Atherton, MG
    Clark, RE
    LEUKEMIA, 2004, 18 (05) : 1025 - 1027
  • [32] Suppression of Bcr-Abl Expression in CML by A Panel of miRNAs
    Iraci, Nunzio
    Valli, Emanuele
    Gherardi, Samuele
    Soverini, Simona
    Kalebic, Thea
    Baccarani, Michele
    Martinelli, Giovanni
    Perini, Giovanni
    BLOOD, 2009, 114 (22) : 351 - 351
  • [33] BCR-ABL Mutations in Chronic Myeloid Leukemia
    Ernst, Thomas
    La Rosee, Paul
    Mueller, Martin C.
    Hochhaus, Andreas
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (05) : 997 - +
  • [34] BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
    不详
    LANCET, 1986, 2 (8501): : 258 - 259
  • [35] Validation of Cepheid® Xpert® BCR-ABL Monitor and Ultra assays used in the molecular monitoring of chronic myeloid leukaemia (CML) patients
    De Long, C.
    Swanepoel, C.
    Paul, L.
    Bassa, F.
    Grewal, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 75 - 76
  • [36] A proportion of primitive haemopoietic progenitor cells in the peripheral blood of patients with chronic phase chronic myeloid leukaemia (CP-CML) are BCR-ABL negative.
    Grand, FH
    Chase, A
    Spencer, A
    Hawkins, T
    Goldman, JM
    Gordon, MY
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 62 - 62
  • [37] Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by in situ amplification
    Pachmann, K
    Zhao, SR
    Schenk, T
    Kantarjian, H
    El-Naggar, AK
    Siciliano, MJ
    Guo, JQ
    Arlinghaus, RB
    Andreeff, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) : 749 - 759
  • [38] The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia
    Jeffs, AR
    Benjes, SM
    Smith, TL
    Sowerby, SJ
    Morris, CM
    HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 767 - 776
  • [39] Comparison of BCR-ABL Transcript Variants Between Patients With Chronic Myeloid Leukaemia and Leukaemia Cell Lines
    Sales, Livia De Oliveira
    Mesquita, Felipe Pantoja
    De Sousa Portilho, Adrhyann Jullyanne
    De Moraes Filho, Manoel Odorico
    Amaral De Moraes, Maria Elisabete
    Montenegro, Raquel Carvalho
    Moreira-Nunes, Caroline Aquino
    IN VIVO, 2019, 33 (04): : 1119 - 1124
  • [40] T lymphoblastic lymphoma with BCR-ABL negative chronic myeloid leukaemia: a novel association
    Faizan, Mahwish
    Anwar, Saadia
    Ul Ain, Rahat
    Zafar, Huma
    Saqlain, Nazish
    Rathore, Zunaira
    ECANCERMEDICALSCIENCE, 2021, 15
12345